跳至主要内容
临床试验/NCT01745237
NCT01745237招募中不适用

Detection and Prognostic Significance of Myocardial Damage Visualized by Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis

Duke University1 个研究点 分布在 1 个国家目标入组 27,000 人开始时间: 2002年9月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
27,000
试验地点
1
主要终点
Pulmonary mortality

研究概览

简要总结

The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.

详细描述

In patients with sarcoidosis, cardiac death is a leading cause of mortality which may represent unrecognized cardiac involvement. Cardiovascular magnetic resonance (CMR) can detect cardiac involvement including minute amounts of myocardial damage. Therefore, the objective of this study was to determine the usefulness of CMR and compare it with standard clinical evaluation for cardiac involvement. Patients with documented extracardiac sarcoidosis or clinically suspected cardiac sarcoidosis will be enrolled.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Biopsy proven sarcoidosis
  • Suspected cardiac sarcoidosis

排除标准

  • Contraindication to MRI

结局指标

主要结局

Pulmonary mortality

时间窗: > 1year

only in subset of patients with pulmonary sarcoidosis

cardiac mortality

时间窗: > 1year

arrhythmic death

时间窗: > 1year

次要结局

  • Cardiac Transplant(> 1 year)
  • all-cause mortality(> 1year)
  • Pulmonary Transplant(> 1 year)
  • arrhythmic events(> 1year)
  • PPM placement/high grade AV block(> 1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Delayed-Enhancement Cardiovascular Magnetic... | 临床试验